International Stem Cell Corp (ISCO): Cash & Equivalents
Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2017-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$304.0K
As of 2017-12-31
-35.1%
3-year compound annual growth
-14.2%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2017-12-31 | $304.0K | +176.4% | 2018-04-09, Balance as of period end |
| 2016-12-31 | $110.0K | -79.3% | 2018-04-09, Balance as of period end |
| 2015-12-31 | $532.0K | -52.1% | 2017-03-31, Balance as of period end |
| 2014-12-31 | $1.11M | -50.5% | 2016-03-30, Balance as of period end |
| 2013-12-31 | $2.24M | +243.0% | 2015-03-30, Balance as of period end |
| 2012-12-31 | $654.0K | -51.1% | 2014-03-17, Balance as of period end |
| 2011-12-31 | $1.34M | -76.9% | 2013-03-26, Balance as of period end |
| 2010-12-31 | $5.78M | +695.3% | 2013-03-26, Balance as of period end |
| 2009-12-31 | $727.0K | n/a | 2012-03-16, Balance as of period end |